# clm_8BB3624F55A2

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: research_and_development  
value: 398,762,000 United States dollar  
valid_from: 2009-12-31  
valid_to: 2010-12-31  
published: 2011-02-17  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DBA4D7F8FE2B  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals research and development: 398,762,000 United States dollar", as of 2009-12-31 (until 2010-12-31). Claim clm_8BB3624F55A2, https://asof.is/claim/clm_8BB3624F55A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-17  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm (primary, SEC EDGAR 10-K FY2010, published 2011-02-17)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 274,903,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_8BB3624F55A2](/claim/clm_8BB3624F55A2.md) | [clm_9548E82DE9F9](/claim/clm_9548E82DE9F9.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.